Quick Takeaways
- TANG CAPITAL MANAGEMENT LLC filed SCHEDULE 13G/A for Tarsus Pharmaceuticals, Inc. Common Stock, par value $0.0001 per share (TARS).
- Disclosed ownership: 5.9%.
- Date of event: 31 Mar 2025.
Quoteable Key Fact
"TANG CAPITAL MANAGEMENT LLC disclosed 5.9% ownership in Tarsus Pharmaceuticals, Inc. Common Stock, par value $0.0001 per share (TARS) on 31 Mar 2025."
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original Filing| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| TANG CAPITAL MANAGEMENT, LLC | 5.9% | 2,454,797 | 0 | 2,454,797 | /s/ Kevin Tang | Manager | |
| KEVIN TANG | 5.9% | 2,454,797 | 0 | 2,454,797 | /s/ Kevin Tang | Self | |
| TANG CAPITAL PARTNERS, LP | 5.6% | 2,334,439 | 0 | 2,334,439 | /s/ Kevin Tang | Manager, Tang Capital Management, LLC, General Partner | |
| TANG CAPITAL PARTNERS INTERNATIONAL, LP | 0.15% | 62,358 | 0 | 62,358 | /s/ Kevin Tang | Manager, Tang Capital Management, LLC, General Partner | |
| TANG CAPITAL PARTNERS III, INC | 0.1% | 43,500 | 0 | 43,500 | /s/ Kevin Tang | Chief Executive Officer | |
| TANG CAPITAL PARTNERS IV, INC | 0.04% | 14,500 | 0 | 14,500 | /s/ Kevin Tang | Chief Executive Officer |